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Abstract
Immunosuppressed persons such as HIV/AIDS patients are at risk of acquiring diarrhoeal infections from water-borne E. coli 
O157:H7. In the present study, we investigated the prevalence of E. coli O157:H7 in drinking water collected from selected 
distribution systems within the Amathole District of the Eastern Cape and its predicted impact on diarrhoeic conditions of 
HIV/AIDS persons living in this area. One hundred and eighty water samples and 360 stool swabs from confirmed and non-
confirmed HIV/AIDS diarrhoeic patients were analysed. Escherichia coli O157:H7 were isolated using enrichment culture 
and confirmed using molecular techniques. 
 Of the 180 drinking water samples, 46 (25.56%) were positive for E. coli O157. The prevalence of E. coli O157 in the 
stools was at 36.39% (131/360) of which 56.5% (74/131) and 43.5% (57/131) were from stools of confirmed and non-confirmed 
HIV/AIDS patients, respectively. Molecular analysis of 27, 25 and 29 representative presumptive E. coli O157 from water and 
stools of confirmed and non-confirmed HIV/AIDS patients, respectively, revealed that 14.81%, 36% and 17.24% of the iso-
lates were E. coli O157:H7. The findings predicted a possible link between E. coli O157:H7 isolated from drinking water and  
diarrhoeic conditions of both confirmed and non-confirmed HIV/AIDS patients visiting Frere Hospital for treatment.
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Introduction
Safe drinking water that complies with the South African 
National Standards (SANS) 241 Drinking Water Specification 
(SANS, 2001) does not pose a significant risk to public health 
(especially for babies, infants, immunosuppressed persons such 
as HIV/AIDS individuals, and the elderly) over a lifetime of 
consumption. This is the norm in almost all South African met-
ropolitan areas. However, in many rural and some peri-urban 
areas, the situation is very different. Prior to 1994, 30 to 40% of 
the South Africa’s population (approximately 14 to 18 m. peo-
ple) was without adequate water supply. As recently as 2004, 
some 4 m. people were still obtaining water from rivers, ponds 
and springs, (Kasrils, 2004), which were usually not treated 
and were faecally contaminated (Muyima and Ngcakani, 1998; 
Momba and Kaleni, 2003; Momba and Notshe, 2003). While 
the present South African Government has implemented many 
rural water supply schemes under the National Reconstruction 
and Development Programme, where rural water supplies do 
exist, drinking water is often of poor quality and considered 
unsafe (Momba et al., 2003; 2004a;b; 2005a;b; 2006a;b; Obi et 
al., 2006). This means that consumers are at risk of contracting 
water-borne diseases even from treated water supplies.
 By the year 2002, a large proportion of the Eastern Cape 
population (68%) still lived below the South African national 
poverty line (UNDP, 2004) and approximately 11% and 38% 
of the population lived in informal and traditional structures, 
respectively. Piped water distribution had reached only 62% of 
households and 31% of households had no toilet facilities (Sta-
tistics South Africa, 2003). The Amathole District Municipality, 
where this research was conducted, is in the Eastern Cape Prov-
ince, which is home to 12.1% of HIV positive persons in South 
Africa (Dorrington et al., 2006). By June 2006, Dorrington et al. 
(2006) reported that the majority of these HIV-positive individu-
als in the Eastern Cape Province were youths with an estimated 
prevalence of 16.4%. The predicted incidence of HIV infections 
in the Eastern Cape Province is at 1.3% and as at June 2006, 
194 443 people had died of HIV/AIDS and another 64 095 peo-
ple were already sick with the disease (Dorrington et al., 2006). 
However, it is not only HIV/AIDS that has ravaged the Eastern 
Cape community; other diseases such as strokes, hypertensive 
heart disease, diarrhoeal diseases, diabetes mellitus and tuber-
culosis have also been reported (Bradshaw et al., 2000).
 The World Health Organization (WHO) estimated that about 
88% of diarrhoeal diseases in the world are attributed to unsafe 
water, sanitation and hygiene. Approximately 3.1% of annual 
deaths (1.7 m.) and 3.7% of the annual health burden (disability-
adjusted life years [DALYSs]) worldwide (54.2 m.) are attrib-
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uted to unsafe water, sanitation and hygiene (WHO, 2003). The 
impact of diarrhoeal diseases is significant in South Africa, with 
annual estimated deaths of about 50 000. Three million cases 
of illnesses and treatment cost the state about R3.4 bn. (Pegram 
et al., 1998; Mackintosh et al., 2002; Sapkota et al., 2004).  The 
most alarming situation is the death of about 20% of all chil-
dren under 5 years of age living in settlements with access to 
rudimentary water supply and sanitation (Bourne and Coetzee, 
1996). 
 Diarrhoea occurs in about 30 to 60 % of HIV/AIDS patients 
in developed countries and in an estimated 90% of such patients 
in developing countries (Sapkota et al., 2004). Epidemiological 
investigations during outbreaks have identified E. coli O157:H7 
as a pathogenic strain that causes severe and life-threatening 
diarrhoea (Galane and Le Roux, 2001). Escherichia coli O157:H7 
infections pose the greatest risk to immunosuppressed individu-
als because it can easily invade the cells of HIV/AIDS patients 
due to a suppressed cell-mediated immunity (Morris and Pot-
ter, 1997; Hoffman, 2004). One of the easily discernable conse-
quences of HIV/AIDS is the long-term implications for effective 
water resource management and the provision of wholesome 
water supplies to communities (Ashton and Ramasha, 2002).
 Although HIV/AIDS and water-borne diarrhoeal diseases are 
among the leading causes of morbidity and mortality in South 
Africa, the association of diarrhoea disease-causing agent such 
as E. coli O157:H7 in drinking water and the diarrhoeal condi-
tions of HIV/AIDS individuals still remains unknown in South 
Africa. We, therefore, conducted the present study to ascertain 
the prevalence of E. coli O157:H7 in drinking water collected 
from selected distribution sources within the Amathole District 
of the Eastern Cape Province and its predicted impact on diar-
rhoeic conditions of HIV/AIDS persons living in this area.
Experimental
Study site
The study was conducted between March 2005 and August 2006. 
The Amathole District was selected based on the researchers’ 
familiarity with the area, HIV prevalence and the presence of a 
referral hospital, Frere Hospital, which is situated in the City of 
East London and caters for HIV/AIDS patients of various races, 
gender and age groups from rural areas of the district.  Fort 
Beaufort, Alice, Dimbaza, Mdantsane, Ngwenya and Kwasaki 
were chosen because potential pathogenic E. coli strains have 
been reported to be predominant in water sources used by these 
communities (Momba and Kaleni, 2003; Momba and Notshe, 
2003; Momba et al., 2004a;b; 2005a;b).
Scientific ethics and informed consent
The University of Fort Hare’s Govan Mbeki Research and Devel-
opment Centre, the Provincial Department of Health (Bisho), 
and the Regional Eastern Cape Ethical Review Committees all 
approved the protocol that was used for the stool swab collection. 
Informed consent was obtained from patients or their guardians 
with the help of a nurse with voluntary counselling and testing 
(VCT) skills and experience. 
Collection of samples
In total, 180 water samples (30 for each site) were collected 
from the standpipes that supplied treated drinking water to the 
communities of Fort Beaufort, Alice, Dimbaza, Mdantsane, 
and untreated groundwater to the communities of Ngwenya 
and Kwasaki, using internationally accepted techniques and 
principles.  
 Three hundred and sixty stool swabs were obtained from 
confirmed HIV/AIDS positive (180 stool swabs) and non-con-
firmed HIV/AIDS (180 stool swabs) diarrhoeic patients visiting 
Frere Hospital for treatment, using sterile cotton swabs (Merck, 
Johannesburg, SA). The stools swabs were dipped in sterile 
specimen bottles filled with 30 m of 1% (w/v) sterile saline 
solutions (Merck, SA). The confirmed HIV/AIDS patients had 
already been tested for HIV at the HIV/AIDS clinic of Frere 
Hospital and were known by the hospital clinicians to be carri-
ers of the HIV virus. The patients’ locations and their diarrhoeal 
conditions and HIV/AIDS status were recorded. Anonymity of 
the patients was protected as much as possible. Diarrhoeic stools 
in this study were diagnosed in the case of patients experiencing 
three or more watery stools in 24 h. The water samples and stool 
swabs were transported on ice in a cooler box and transported 
to the laboratory for the isolation of E. coli O157:H7. Microbiol-
ogical analyses were performed within 1 to 4 h of their collec-
tion.
Isolation of E. coli O157:H7 
Escherichia coli O157:H7 from water samples and stool swabs 
of patients was isolated using a pre-enrichment process followed 
by immunomagnetic separation and spread-plate procedure. For 
pre-enrichment, 1 mℓ of water sample or saline stool swab sus-
pension was added to 99 mℓ of modified E. coli (mEC) broth con-
taining 20 µg·mℓ-1 of Novobiocin (n) (Merck, SA) (Heuvelink et 
al., 1998). The samples were incubated for 8 h at 37oC on a rotary 
shaker (143 × g) (Gallenkamp, Loughborough, England). There-
after, 1 mℓ of pre-enriched water sample or stool swab suspen-
sion was added to an Eppendorf tube(Eppendorf, SA) containing 
20 µ·mℓ-1 of magnetic beads coated with antibody to O157. 
 Immunomagnetic separation (IMS) proceeded as described 
by the Dynabead manufacturer (Dynal Product Brochure, 
2006). The bacterial-IMS bead complex were re-suspended into 
1% (w/v)  sterile Phosphate Buffered Saline (PBS) (Merck, SA) 
and 50 µℓ of this bacterial-IMS concentrate was spread in dupli-
cate onto Sorbitol-MacConkey agar supplemented with cefixime 
(0.05 mg·mℓ-1) and potassium tellurite (2.5 mg·mℓ-1) (CT-SMAC) 
(Merck, SA) agar plates (Müller et al., 2003). The plates were 
then incubated at 37°C for 24 h. Sorbitol-non-fermenting colo-
nies (up to 5 colourless colonies per plate per sample) were ran-
domly selected and further plated onto Eosin Methylene Blue 
(EMB) agar (Merck, SA). Forty six water samples and 74 and 57 
stools from confirmed and non-confirmed HIV/AIDS patients 
respectively, had presumptive E. coli O157 with greenish blue 
black metallic sheen on EMB agar.
Identification of E. coli O157 
Escherichia coli O157 colonies were identified as described by 
Cagney et al. (2004). The Oxidase test was performed on the 
colonies that were Gram negative prior to the conventional 
indole-methyl red-Voges-Proskauer-citrate (IMViC) tests (Heu-
velink et al., 1998; Müller et al., 2003). Colonies of presumptive 
E. coli O157 each representing the 46 water samples and 74 and 
57 stool samples from confirmed and non-confirmed HIV/AIDS 
patients respectively, were subjected to IMViC test and further 
confirmed as E. coli with API 20E kits. 
 The strips were read and final identification was secured 
using API LAB PLUS computer software (BioMérieux, Marcy-
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Etoile, France) (Momba et al., 2006b). Of the 46 water samples, 
74 and 57 stool swabs of confirmed and non-confirmed HIV/
AIDS patients, respectively, only 27, 25 and 29 representative 
E. coli O157 from these respective samples had 99.9% profile for 
E. coli with API PLUS computer software program, thus these 
were used for molecular characterisation.
Molecular characterisation of E. coli O157:H7 using 
polymerase chain reaction (PCR)
Bacterial DNA extraction
DNA was extracted from colonies identified as E. coli O157 
and also from a positive control strain (E. coli O157:H7, ATCC 
43895) purchased from the Microbiology Department of the 
National Health Laboratory Services (NHLS), Johannesburg, 
South Africa. The extraction was performed according to the 
method previously used by Torres et al. (2003). Briefly, a loop-
full of overnight culture of E. coli colonies was suspended in 200 
µℓ  of sterile Milli-Q PCR grade water (Merck, SA) and the cells 
were lysed using a Dri-block DB.2A (Techne, Cape Town, SA) 
for 15 min at 100oC. The cell debris was removed by centrifuga-
tion at 20 000 × g for 2 min using a MiniSpin micro-centrifuge 
(Merck, SA). The lysate supernatant was placed on ice for 5 min. 
Sterile Milli-Q PCR grade water (Merck, SA) was included in 
each PCR assay as a negative control. 
Amplification of fliCH7, rfbEO157 and eaeA genes
Oligonucleotide primers specific for the targeted fliCH7, rfbEO157 
and eaeA genes used in the polymerase chain reaction (PCR) were 
similar to those used by Wang et al. (2002) (Table 1). Three sets 
of primer mixtures were prepared according to the method used 
by Wang et al. (2002). A total volume of 10 μℓ genomic DNA was 
used in each PCR reaction. The PCR assays for fliCH7, rfbEO157 
and eaeA genes were carried out in a 50 μℓ reaction volume con-
taining 10× SuperTherm GOLD Buffer, 1.5 mM MgCl2, each of 
the four deoxynucleoside triphosphates (dNTPs) (Southern Cross 
Biotechnology, SA) at a concentration of 0.25 mM, 100 pmol for 
each of fliCH7, rfbEO157 and eaeA specific primers, and 5 U of Taq 
DNA polymerase (Southern Cross Biotechnology, SA). 
 The reaction was carried out in the Eppendorf model AG 
22331 Thermocycler (Merck, SA). The following PCR condi-
tions for fliCH7, rfbEO157 and eaeA genes optimised in our labora-
tory were similar to those previously used by Wang et al. (2002). 
Initial denaturation at 95°C for 8 min; followed by 30 cycles of 
amplification, denaturation at 95°C for 30 s, annealing at 58°C 
for 30 s, and extension at 72°C for 30 s. The final extension 
cycle was followed by incubation at 72°C for 7 min and cooling 
to 4°C. 
DNA electrophoresis
The amplicons (10 μℓ aliquots) were visualised on a 2% (w/v) 
agarose gel (Merck, SA) in 1 U TAE buffer (40 mM Tris-HCl, 
20 mM Na-acetate, 1 mM EDTA, pH 8.5) and stained with 0.5 
µg.mℓ-1 ethidium bromide (EtBr) (Merck, SA). The amplified 
products were photographed under the BioDoc-It System (UVP 
Upland, CA 91786, USA). A 100-bp DNA ladder (Promega, 
Madison, USA) was included on each gel as a molecular size 
standard. The electrophoresis was carried out at 76 V for 1 h.
Statistical analysis 
The statistical analysis was done by use of SAS program (SAS 
Institute, Cary, NC). The Chi square test was used to establish 
the significance difference between the prevalence rates of 
E coli O157:H7 in stool samples of confirmed HIV/AIDS patients 
and those of non-confirmed HIV/AIDS patients. The Chi square 
test was run at a statistical significance level of (P ≤ 0.05). 
Results
Prevalence of E. coli O157 in water samples
Of the 180 drinking water samples, 46 (25.56 %) were positive 
for E. coli O157.  Water samples collected from Fort Beaufort, 
Alice and Dimbaza, Mdantsane, Ngwenya and Kwasaki were 
positive at prevalence rates of 16.67% (5/30), 30% (9/30), 30% 
(9/30), 13.33% (4/30), 36.67% (11/30) and 26.67% (8/30) respec-
tively (Fig. 1). 
TABLE 1
Base sequences, locations and predicted sizes of amplified products for fliCH7, rfbEO157  
and eaeA specific oligonucleotide primers (Wang et al., 2002)
Primer 
Set 




A FliC-a TAC CAT CGC AAA AGC AAC TCC fliCH7 1068–1088 247
FliC-b GTC GGC AAC GTT AGT GAT ACC 1314–1294
B RfbE-a   CTA CAG GTG AAG GTG GAA TGG rfbEO157 673–693 327
RfbE-b AATT CCT CTC TTT CCT CTG CGG 999–979
C EAE-a    ATG CTT AGT GCT GGT TTA GG eaeA 132–151 248
EAE-b    GCC TTC ATC ATT TCG CTT TC 379–360
 
 




Prevalence of presumptive E. coli O157 in drinking water from 
various distribution points in Amathole district. The ‘n’ sample 
size was 30 for all the sampling locations.
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Prevalence of E. coli O157 in stool specimens of  
diarrhoeic patients
Of the 360 stool swabs of diarrhoeic patients, 131 (36.39%) were 
positive for E. coli O157. About 56.5% (74/131) were from con-
firmed HIV/AIDS diarrhoeic patients and 43.5% (57/131) were 
from non-confirmed HIV/AIDS diarrhoeic patients (Fig. 2). By 
location, the prevalence of E. coli O157 was at 75.7% (56/74) for 
confirmed HIV/AIDS patients and 73.6% (42/57) for non-con-
firmed HIV/AIDS patients originating from East London. 
 Another location that had a noticeable prevalence of E. coli 
O157 for the confirmed HIV/AIDS patients was Stutterheim 
4.05% (3/74) whereas locations such as Duncan Village and 
Mdantsane had a prevalence of 2.7% (2/74).  The rates of E. coli 
O157 prevalence for the other locations of the non-confirmed 
HIV/AIDS patients were 5.26% (3/57) for Butterworth, 3.51% 
(2/57) for Duncan Village, King Williams Town and Stutterheim 
whereas Mdantsane had no E. coli O157. Localities, which had 
very low numbers of patients, were categorised as ‘Others’ and 
E. coli O157 prevalence for confirmed HIV/AIDS patients from 
such locations was 9.5% (7/74) whereas for the non-confirmed 
HIV/AIDS patients the prevalence was 8.77% (5/57). Although 
the study focused on the Amathole District Municipality and the 
majority of the patients who visited Frere Hospital originated 
from this district, some of the patients originated from other dis-
tricts (Table 2). The χ2 value of 0.058 predicted that HIV/AIDS 
status was a significant variant for E. coli O157 infection. The 
arguments were based on the statistical significance level at 
which the χ2 test was run (P ≤ 0.05).
Molecular characterisation of isolates 
Water samples isolates identified by biochemical profiles for 
E coli O157 that were positive by PCR for fliCH7, rfbEO157, and 
eaeA genes characteristics of E. coli O157:H7 are summarised 
in Table 3.  Of the 27 water samples positive for E. coli O157 
isolates, 4 (14.81%) carried fliCH7, rfbEO157 and eaeA genes 
whereas 3.70% (1/27) was only positive for fliCH7 gene. The 
three target genes of E. coli O157:H7 (fliCH7, rfbEO157, and eaeA) 
under the present study were noticed in isolates obtained from 
Dimbaza, Fort Beaufort, Ngwenya and Mdantsane water sam-
ples. Representative gel electrophoretic profiles of amplified 




Prevalence of presumptive E. coli O157 in diarrhoea confirmed 
and non-confirmed HIV/AIDS patients visiting Frere Hospital, 
East London. ‘n’  sample size was 131 for patients presumptively 
positive for E. coli  O157:H7.
TABLE 2
Patients visiting Frere Hospital in East London 
for the treatment of diarrhoea (March 2005 and 
August 2006)






Amathole Berlin 1(3) 1(8)
Duncan Village 2(4) 2(3)
East London 56(80) 42(86)





OR Tambo Umtata 0(0) 0(1)
Chris Hani Queenstown 0(0) 0(1)
Ethekwini Durban 1(0) 0(0)
Total number of patients 74(106) 57(123) = 
N= 360
aRepresents locations where only one patient who was either con-
firmed or non-confirmed HIV/AIDS with diarrhoea came from while 
visiting Frere Hospital for treatment during the study period. These 
locations included Cathcart, Chulumra, Idutywa, Kentani, Ped-
die and Tshomo. Others were Elliot, Engobo, Mooiplaas, Peddie 
and Southern Wood for the confirmed HIV/AIDS patients. On the 
other hand, locations for the non-confirmed patients categorised 
as others also included Alice, Bedford, Willowvale, Kentani and 
Mooiplaas, Cala, Cathcart, Chulumra and Gombia, Idutywa, Jon-
golanya, Komga and McClean Town. The numbers in parenthesis 
are patients whose stool swabs were negative for E. coli O157:H7 
even though they had diarrhoea.
TABLE 3
Summarised PCR amplified genes of E. coli O157:H7 
isolated from drinking water from various distribu-
tion points in Amathole district
Water 
source
Amplified genes Water 
samples 
positive 
for E. coli 
O157:H7
fliCH7 rfbEO157 eaeA
aAlice + – – 0
Dimbaza + + + 1
Fort Beaufort + + + 1
Ngwenya + + + 1
Mdantsane + + + 1
Total number of water samples positive with 
E. coli O157:H7
4(a1)
‘+’ target gene present, ‘–’ target gene absent.  n = 27 Representa-
tive number of presumptive E. coli O157 characterised by PCR. 
a Represents water samples whose E. coli O157 only had either 1 or 
2 of the targeted genes. These water samples were not considered 
as being positive for E. coli O157:H7 due to the absence of the other 
genes.
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 Molecular analysis of isolates obtained from stool speci-
mens of diarrhoeic patients revealed that fliCH7, rfbEO157 and 
eaeA genes were present in 9 of the 25 (36%) E. coli O157 
isolates from stool swabs of confirmed HIV/AIDS diarrhoeic 
patients (Table 4). On the other hand, only 5 of the 29 (17.24%) 
of E. coli isolates from stool swabs of non-confirmed HIV/AIDS 
diarrhoeic patients carried fliCH7, rfbEO157 and the attaching and 
effacing (eaeA) genes (Table 5). Representative gel electro-
phoretic profiles of amplified products of target genes for E. coli 
O157:H7 are illustrated in Fig. 4. 
Discussion and conclusion
The present study revealed important findings on the prevalence 
of E. coli O157 in the drinking water supplied to the commu-
nities of Fort Beaufort, Alice, Dimbaza, Mdantsane, Ngwenya 
and Kwasaki.  A higher E. coli O157 prevalence rate was noted 
in water samples collected from Ngwenya groundwater samples 
(36.66%) while a lower prevalence rate was recorded in Fort 
Beaufort treated drinking water samples (16.66%) (Fig. 1). With 
the exception of the water samples collected from Alice, which 
showed only one target gene ( fliCH7) (Table 3), the PCR success-
fully amplified the three target genes (fliCH7, rfbEO157 and eaeA) 
of the E. coli O157:H7 from the isolates obtained from the drink-
ing water samples (Table 3, Fig. 3). 
 The results of this study confirm the poor microbiological 






























Summarised PCR amplified genes of E. coli O157:H7 




Amplified genes Patients posi-





Cathcart + + + 1
Duncan Village + + + 1
East London + + + 6
aEast London + – – 0
aEast London + + – 0
aGompo + – – 0
Stutterheim + + + 1
Total number of stool specimens positive 
with E. coli O157:H7
9(a3)
‘+’ target gene present, ‘–’ target gene absent.  n = 25 Representa-
tive number of presumptive E. coli O157 characterised by PCR. 
a Represents patients whose E. coli O157 only had either 1 or 2 of the 
targeted genes. These patients were not considered as being posi-
tive for E. coli O157:H7 due to the absence of the other genes.
Figure 4
The amplified fliCH7, rfbEO157 and eaeA 
gene of E. coli O157:H7 isolated from stool 
swabs of (a) confirmed HIV/AIDS (b) non-
confirmed HIV/AIDS patients all with diar-
rhoea. Lanes M1 & M2: 100 bp DNA ladder 
marker (Promega, USA). All Lanes 1 and 
7: Positive (E. coli O157:H7, ATCC 43895) 
and negative controls, respectively. In (a) 
Lanes 2: F235, Lanes 3: F237, Lanes 4: F242, 
Lanes 5: F247, Lanes 6: F323 whereas in (b) 
Lanes 2:  F7, Lanes 3: F116, Lanes 4: F117, 
Lanes 5: F125 and Lanes 6: F355. The ex-
pected molecular sizes of fliCH7, rfbEO157 and 
eaeA fragments were at 247 bp, 327 bp and 
248 bp respectively.
Figure 3
The amplified fliCH7, rfbEO157 and eaeA gene 
of E. coli O157:H7 isolated from drinking 
waters from Ngwenya, Dimbaza, Mdant-
sane and Fort Beaufort. Lanes M1 & M2: 
100 bp DNA ladder marker (Promega, 
USA), Lane 1: Positive control (E. coli 
O157:H7, ATCC 43895), Lane 2:NgweW4, 
Lane 3: DimW9, Lane 4: MdaW27, Lane 5: 
FbW27, Lane 6: Negative control. The ex-
pected molecular sizes of  fliCH7, rfbEO157 
and eaeA fragments were at 247 bp, 327 bp 
and 248 bp respectively.
TABLE 5
Summarised PCR amplified genes of E. coli O157:H7 




Amplified genes Patients posi-
tive for E. coli 
O157:H7
fliCH7 rfbEO157 eaeA
East London + + + 5
aEast London + + – 0
aEast London – + – 0
Total number of stool specimens positive 
with E. coli O157:H7
5(a2)
‘+’ target gene present, ‘–’ target gene absent.  n = 29 Representa-
tive number of presumptive E. coli O157 characterised by PCR. 
a Represents patients whose E. coli O157 only had either 1 or 2 of the 
targeted genes. These patients were not considered as being posi-
tive for E. coli O157:H7 due to the absence of the other genes.
Available on website http://www.wrc.org.za
ISSN 0378-4738 = Water SA Vol. 34 No. 3 July 2008
ISSN 1816-7950 = Water SA (on-line)
370
treatment plants in the Eastern Cape Province. From Octo-
ber 2004 to November 2004 and from July to September 
2005, a survey of 55 water treatment plants was conducted 
in 5 district municipalities (Cacadu, Chris Hani, Amathole, 
Ukhahlamba and O.R. Tambo) of the Eastern Cape Province 
by Momba et al. (2006b). Of these 55 water treatment plants, 
only 18% complied with the South African National Stand-
ards 241 Drinking Water Specification (SANS, 2001). Total 
and faecal coliforms were recorded at the points of treatment 
as well as at the consumers’ taps. Among 26 bacterial spe-
cies identified during the survey, E. coli was predominant in 
treated drinking water supplied to the communities of the 
above-mentioned 5 district municipalities (Momba et al., 
2006a). In another study conducted between 2001 and 2002, 
the polymerase chain reaction analysis using UidaA-specific 
primers revealed that a genetic region homologous in size to 
the E. coli UidaA structural gene was present in Ngwenya 
and other groundwater sources used by the communities for 
domestic consumption (Momba et al., 2006b). These studies 
and the present investigation gave conclusive evidence that 
the microbiological quality of drinking water supplied to the 
Eastern Cape communities poses a high risk to the health of 
these communities, especially to immunosuppressed indi-
viduals such as those infected by HIV/AIDS. 
 Cultural methods using IMS and selective media followed 
by biochemical tests indicated that the stool samples collected 
from diarrhoeic confirmed and non-confirmed HIV/AIDS 
patients who visited Frere Hospitals in the Amathole District 
Municipality had E. coli O157 at prevalence rates of 56.5% 
(74/131) and 43.5% (57/131) respectively. Moreover, the bur-
den of E. coli O157 in both confirmed and non-confirmed HIV/
AIDS individuals was not limited only to the localities within 
the Amathole District, but also felt across a large number of 
the localities in the Eastern Cape Province (Table 2).  Repre-
sentative stool isolates identified by biochemical profiles for 
E. coli O157 and subjected to PCR for the amplification of the 
three target genes (fliCH7, rfbEO157 and eaeA) unravelled E. coli 
O157:H7 at prevalence rates of 36% (9/25) and 17.24% (5/29) for 
confirmed and non-confirmed diarrhoeic HIV/AIDS patients, 
respectively (Fig. 4). 
 The χ2 value of 0.058 predicted that HIV/AIDS status was a 
significant variant for E. coli O157 infection compared to non-
confirmed HIV/AIDS individuals (P ≤ 0.05). The molecular pro-
file of results also indicated that HIV/AIDS patients were more 
susceptible to E. coli O157:H7 than non-confirmed HIV/AIDS 
patients (Tables 3 and 4). Studies of diarrhoeal cases have been 
reported in both immunocompetent and immunosuppressed per-
sons such as those suffering from HIV/AIDS (Obi and Bessong, 
2002; Obi et al., 2003; 2006; 2007). However, it is important 
to recognise that E. coli O157:H7 infections pose the greatest 
risk to immunosuppressed individuals (Morris and Potter, 1997; 
Hoffman, 2004).
 Although only representative E. coli O157 isolates identi-
fied by culture-based methods and biochemical tests were sub-
jected to PCR assays, low prevalence rates of E coli O157:H7 
from both water and stool samples were noted (Table 3 and 4). 
It is interesting to note that the PCR assays were limited only to 
the amplification of the three target genes ( fliCH7, rfbEO157 and 
eaeA) characteristics of the enterohaemorrhagic E. coli O157:H7 
serotype under this investigation. Most important is the fact that 
there are other verotoxigenic E. coli (VTEC) such as E. coli 
O157: H─ (Hussein and Stanley, 2003). Other virulence as well 
as putative genes that have been used in the characterisation 
of E. coli O157:H7 include but are not limited to EHEC hlyA, 
stx1 and stx2, which in some instances may also be referred to 
as vt1 and vt2 and E. coli 16s rRNA (Wang et al., 2002; Cagney 
et al., 2004). Different variants of stx2 such as stx2c, stx2d, stx2e 
and stx2f, have also been reported (Wang et al., 2002). In addi-
tion, other virulence factors as well may be involved in E. coli 
O157 pathogenesis (Dean-Nystrom et al., 1998). Consequently, 
the high prevalence of E. coli O157 could be linked to the pres-
ence of other serotypes of E. coli O157 in water samples and in 
stools of diarrhoeic patients. No amplified product could then be 
expected from isolates that did not have the target genes of E. 
coli O157:H7 under this investigation.  
 Water-borne E. coli O157:H7 transmissions have been 
attributed to the ingestion of contaminated drinking water or 
recreational waters (Keen et al., 1994; Armstrong et al., 1996; 
Friedman et al., 1999). Epidemiological studies have identi-
fied that only small numbers of E. coli O157:H7 (e.g. 10-200 of 
organisms) are needed to cause diarrhoeal infections (Wilshaw 
et al., 1994). Considering the microbiological quality of drinking 
water in the Eastern Cape in general and that of the Amathole 
District in particular and the profile of the molecular results of 
the present study, drinking water might be the source of E. coli 
O157:H7 in stool samples of confirmed and non-confirmed HIV/
AIDS patients. This study therefore predicts a possible epide-
miological link between the E. coli O157:H7 isolated from the 
drinking water and the diarrhoeic conditions of both confirmed 
and non-confirmed HIV/AIDS patients visiting Frere Hospital 
for treatment. 
 Although the PCR assays were able to amplify the E. coli 
O157:H7 genes (fliCH7, rfbEO157 and eaeA) from water and stool 
of both confirmed and non-confirmed HIV/AIDS patients, more 
concern has been raised for confirmed HIV/AIDS patients as the 
results of this study revealed a significantly higher prevalence 
rate of E. coli O157:H7 in the stools of these patients.  Further-
more, the results clearly indicated, especially in East London, 
which is one of the big cities in the Eastern Cape Province, 
the highest rate of E. coli O157:H7 in the stool specimens of 
confirmed HIV/AIDS patients in the Amathole district, which 
includes Alice, Dimbaza, Fort Beaufort, Ngwenya, Kwasaki and 
Mdantsane locations. With the migration of people from one 
location to another or from the locations to the city, consumption 
of drinking water from these locations by HIV/AIDS patients 
might result in diarrhoeal infections.
 A study by Obi et al. (2005) in the Limpopo Province of 
South Africa actually confirmed the presence of enteric patho-
gens (such as Salmonella enteritidis, Salmonella typhimurium, 
Shigella dysenteriae, and verotoxigenic E. coli (different from 
E. coli O157:H7) in the waters consumed by diarrhoeic and non-
diarrhoeic HIV/AIDS positive individuals. The authors con-
cluded that there was a possibility of HIV/AIDS patients being 
infected by these pathogens due to their suppressed immune sys-
tem (Obi et al., 2005). 
 The poor microbiological quality of drinking water and 
especially the presence of pathogenic E. coli strains, including 
enterohaemorrhagic E. coli O157:H7 in drinking water could 
clearly explain how diarrhoeal diseases become endemic in the 
region and continue to ravage the Eastern Cape communities 
(Bradshaw et al., 2000). In addition to bloody diarrhoea, E. coli 
O157:H7 causes hemorrhagic colitis (HC) and haemolytic-urae-
mia syndrome (HUS) in humans (Dean-Nystrom et al., 1998; 
Ritchie et al., 2003). The provision of safe drinking water is a 
basic human right and essential to the health of rural communi-
ties of the Eastern Cape in general and the Amathole District in 
particular. This study and other studies conducted in the prov-
ince (Momba et al., 2006a; 2006b) therefore, alert the Eastern 
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Cape Local Government to address the safety of drinking water 
supplied to rural communities in order to protect the health of 
their populations.
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